abstract |
Pharmaceutical compositions comprising at least one compound of e.g. the formulas (Ie) and a pharmaceutically acceptable carrier which is useful in a medicine n n n n n n n n n n wherein the symbols and substituents have the following meaningn n—X— is e.g.n n n n n n n n n n n and Y is e.g. n n n n n n n n n n or the pharmaceutically acceptable salts, esters or amides and prodrugs of the above identified compounds can be applied to modulate the in-vitro and in-vivo binding processes mediated by E-, P- or L-selectin binding. |